We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+27.69%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$26.3M
Cap. Flow
+$6.69M
Cap. Flow %
4.52%
Top 10 Hldgs %
32.18%
Holding
69
New
7
Increased
42
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
ENGN icon
enGene Therapeutics
ENGN
+$4.49M
2
PCYO icon
Pure Cycle
PCYO
+$2.04M
3
BCYC
Bicycle Therapeutics
BCYC
+$1.91M
4
BSET icon
Bassett Furniture
BSET
+$1.84M
5
FULC icon
Fulcrum Therapeutics
FULC
+$1.74M

Top Sells

Rank Stock Value
1
CVGI icon
Commercial Vehicle Group
CVGI
+$2.28M
2
FDMT icon
4D Molecular Therapeutics
FDMT
+$2.21M
3
FONR
Fonar
FONR
+$2.11M
4
TWIN icon
Twin Disc
TWIN
+$1.62M
5
KVHI icon
KVH Industries
KVHI
+$1.58M

Sector Composition

Rank Sector Weight
1 Industrials 21.12%
2 Healthcare 19.35%
3 Consumer Discretionary 16.44%
4 Real Estate 9.39%
5 Consumer Staples 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HURC icon
1
Hurco Companies Inc
HURC
$149M
$6.06M 4.09%
264,792
+19,924
+8% +$359K
CLDT
2
Chatham Lodging
CLDT
$637M
$6.05M 4.08%
457,149
+7,128
+2% +$73.7K
ALCO icon
3
Alico
ALCO
$300M
$4.86M 3.28%
117,439
-16,253
-12% -$674K
ACTG icon
4
Acacia Research
ACTG
$436M
$4.64M 3.13%
994,770
-96,566
-9% -$464K
FLGT icon
5
Fulgent Genetics
FLGT
$540M
$4.6M 3.1%
224,207
+3,580
+2% +$60.7K
CLW icon
6
Clearwater Paper
CLW
$336M
$4.55M 3.07%
289,906
+75,385
+35% +$1.14M
LMNR icon
7
Limoneira
LMNR
$250M
$4.48M 3.02%
340,880
+92,537
+37% +$1.19M
OSUR icon
8
OraSure Technologies
OSUR
$248M
$4.43M 2.99%
993,875
-24,601
-2% -$87K
TBI
9
Trueblue
TBI
$326M
$4.19M 2.83%
601,005
-39,005
-6% -$217K
ASLE icon
10
AerSale
ASLE
$269M
$3.84M 2.59%
607,358
+110,484
+22% +$722K
ALOT icon
11
AstroNova
ALOT
$3.79M 2.56%
133,065
+2,087
+2% +$33.4K
STHO icon
12
Star Holdings Shares of Beneficial Interest
STHO
$119M
$3.77M 2.54%
412,468
+6,495
+2% +$56.1K
SENEA icon
13
Seneca Foods Class A
SENEA
$1.35B
$3.59M 2.42%
20,648
+356
+2% +$52.9K
HOFT icon
14
Hooker Furnishings Corp
HOFT
$144M
$3.48M 2.35%
195,224
+3,064
+2% +$41.9K
JOUT icon
15
Johnson Outdoors
JOUT
$481M
$3.07M 2.07%
66,748
+1,069
+2% +$50.8K
SEG
16
Seaport Entertainment Group
SEG
$343M
$2.92M 1.97%
109,851
+17,345
+19% +$408K
UFI icon
17
UNIFI
UFI
$139M
$2.76M 1.87%
581,977
+9,174
+2% +$36.5K
MEI icon
18
Methode Electronics
MEI
$646M
$2.74M 1.85%
144,272
+3,630
+3% +$37.5K
VRA icon
19
Vera Bradley
VRA
$94.1M
$2.66M 1.8%
684,766
-149,341
-18% -$551K
TUSK icon
20
Mammoth Energy Services
TUSK
$149M
$2.63M 1.77%
807,804
+207,999
+35% +$609K
MXCT icon
21
MaxCyte
MXCT
$126M
$2.61M 1.76%
2,125,752
+793,559
+60% +$791K
CATO icon
22
Cato Corp
CATO
$52.9M
$2.52M 1.7%
778,940
+12,115
+2% +$36.9K
KVHI icon
23
KVH Industries
KVHI
$136M
$2.48M 1.67%
249,907
-164,831
-40% -$1.58M
KELYA icon
24
Kelly Services Class A
KELYA
$600M
$2.36M 1.59%
192,461
+22,512
+13% +$234K
MED icon
25
Medifast
MED
$136M
$2.36M 1.59%
222,576
+3,513
+2% +$40.5K
1
2 3

Similar funds

VIS
Vertex Investment Solutions Chiyoda-Ku $148M AUM
SA
Sacks & Associates Warren, New Jersey $148M AUM
NCM
Nitor Capital Management Englewood Cliffs, New Jersey $148M AUM
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
PPWM
Perissos Private Wealth Management Bethany, Oklahoma $148M AUM 24.7% 1-Year Est. Return
AAG
Accordant Advisory Group Annapolis, Maryland $148M AUM 23.8% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $148M AUM
MCM
Moon Capital Management New York $148M AUM 25.37% 1-Year Est. Return

Peapod Lane Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Peapod Lane Capital held 69 positions worth $148M, up 22% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Peapod Lane Capital deployed $6.69M of net new capital in Q2 2026, opening 7 new positions and adding to 42 existing holdings. Its largest new stake was enGene Therapeutics: 1,102,149 shares worth $1.91M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Commercial Vehicle Group, an estimated $2.28M trimmed.

  • Peapod Lane Capital's largest Q2 2026 buy was enGene Therapeutics: 1,102,149 shares worth $1.91M.
  • Peapod Lane Capital added most to Bicycle Therapeutics in Q2 2026, an estimated $1.91M increase.
  • Peapod Lane Capital's biggest Q2 2026 reduction was Commercial Vehicle Group, cutting an estimated $2.28M.
  • Peapod Lane Capital fully exited 4D Molecular Therapeutics in Q2 2026, selling an estimated $2.21M.
  • Peapod Lane Capital's ten largest holdings make up 32% of its $148M portfolio in Q2 2026.
  • Peapod Lane Capital opened 7 new positions and closed 8 in Q2 2026.
  • Peapod Lane Capital's portfolio value rose 22% quarter-over-quarter to $148M.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.